A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets

• Status: Withdrawn
• Trial end date: 2012-02-20

Summary

A study to determine whether a new formulation of methylprednisolone suspension is bioequivalent to methylprednisolone tablets.

• Phase: Phase 1

Details

• Lead Sponsor: Pfizer
• Treatments: Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate